Key Financial Data Of Group

Chiome Bioscience Inc. - Filing #7338472

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
2023-01-01 to
2023-03-31
Key financial data of group
Business results of group
Net sales
129,644,000 JPY
682,464,000 JPY
169,404,000 JPY
Ordinary profit (loss)
-303,019,000 JPY
-1,217,240,000 JPY
-227,433,000 JPY
Net assets
1,247,567,000 JPY
1,157,723,000 JPY
1,562,132,000 JPY
Total assets
1,753,934,000 JPY
1,751,454,000 JPY
2,085,676,000 JPY
Basic earnings (loss) per share
-5.60
-24.62
-4.70
Diluted earnings per share
Equity-to-asset ratio
0.704 xbrli:pure
0.651 xbrli:pure
0.743 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.